Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

No cure for female pattern hair loss, but various effective treatments exist.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Flutamide reduces hair growth better but has more side effects.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Finasteride improves acne and hair loss in women with normal testosterone.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.